![Michael Sherman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Michael A. Sherman is currently Director at The Children's Museum of Indianapolis, Inc. since 2012, Director at TOLREMO therapeutics AG, Independent Director at Werewolf Therapeutics, Inc. since 2021, and Independent Director at Aktis Oncology, Inc. starting in 2025.
Former roles include President, Chief Executive Officer & Director at Endocyte, Inc. from 2017 to 2018, Chairman at Chimerix, Inc. from 2023 to 2025, Independent Director at BioSpecifics Technologies Corp.
in 2020, Independent Director at Mead Johnson Nutrition Co. from 2015 to 2017, Vice President-Finance & Strategic Planning at Guidant Corp.
from 2004 to 2006, and Principal at Eli Lilly & Co. Education includes undergraduate studies at DePauw University and an MBA from Tuck School of Business at Dartmouth.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 27/05/2021 |
| AKTIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/08/2025 |
The Children's Museum of Indianapolis, Inc.
 The Children's Museum of Indianapolis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides children's museum services | Direttore/Membro del Consiglio | - |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| CHIMERIX, INC. | Amministratore Delegato | 01/08/2023 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Direttore/Membro del Consiglio | 02/12/2020 |
| ENDOCYTE, INC. | Amministratore Delegato | 21/12/2018 |
| MEAD JOHNSON NUTRITION CO | Direttore/Membro del Consiglio | 15/06/2017 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Direttore Finanziario/CFO | 01/10/2006 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Mead Johnson Nutrition Co.
 Mead Johnson Nutrition Co. Food: Meat/Fish/DairyConsumer Non-Durables Produces infant and children's nutrition products | Consumer Non-Durables |
DePauw University
 DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
The Children's Museum of Indianapolis, Inc.
The Children's Museum of Indianapolis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides children's museum services | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Commercial Services |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
